Mallinckrodt Agrees to Pay $260 Million to Resolve Alleged Medicaid Rebate Underpayment and Patient Kickbacks
Pharmaceutical company Mallinckrodt ARD LLC has agreed to pay $260 million to resolve allegations that it underpaid Medicaid rebates due for its hormone-based anti-inflammatory drug H.P.
🔒 Members Only · Compliance & Enforcement BriefYou’ve reached the member portion of this brief.Members read the full analysis and the source documents in every Brief, six days a week.